APPLICATION PROCEDURE TO CHAIR / ORGANIZE
AN EHA-ESH TYPE II HEMATOLOGY TUTORIAL
INTRODUCTION
Clinicians and scientists who are interested in organizing a Type II Hematology Tutorials are
welcome to apply and develop the scientific program in close collaboration with the Tutorial
Unit.
This document contains information about the Tutorial format, the application procedure and
the responsibilities of the organizers.
TUTORIAL FORMAT
Type II Hematology Tutorials are interactive courses designed for a maximum of 150
participants aiming to provide laboratory and clinical hematologists with an integrated
diagnostic and clinical work-up of hematological disorders. The scientific program takes the
participants through the diagnostic and clinical pathway of malignant diseases.
Tutorials consist of three types of sessions:
1. Plenary lectures (approx 45 minutes is allocated for a lecture )
2. Interactively conducted clinical case study sessions presented as PowerPoint Slides.
(approx. 30 minutes for presenting and discussing one clinical case)
3. Interactively conducted self-assessment test-cases based on clinical cases using
PowerPoint Slides and Voting Box System allowing participants to individually register
their responses to multiple choice questions and to see how their responses compare
with those of the other participants. (approx. 15 minutes for presenting and discussing
one self-assessment case)
Type II Hematology Tutorials are part of EHA’s Outreach program. They use lectures and the
clinical cases and self-assessment test-cases presented for the first time at Type I Hematology
Tutorials available on EHATol on-line platform (www.ehatol.org). The Chair of EHA’s Tutorial
Unit is responsible for selecting the cases and self-assessment case studies from the
database according to the topics selected by the Chair(s).
Type II Hematology Tutorials are chaired by (and the Faculty is composed of) local speakers
with the support of at least one member of the EHATol Unit. The official language of Type II
Hematology Tutorials is English. The courses last 2 to 2.5 days. For each day, 2 to 3 session
topics should be planned.
APPLICATION PROCEDURE
Applications are examined by the EHATol Unit.
If you would like your application to be considered, please prepare and send the following
documents by email to EHA attn. Victoria Chuvakova at v.chuvakova@ehaweb.org
1. Your name and full contact information of your organization
2. Suggested list of 2-3 co-chairs
3. Preliminary dates for the tutorial (chairs should undertake to ensure that other major
meetings covering similar topics do not coincide with the meeting they would like to
organize).
4. The proposed Main topic of the Tutorial
5. A description of the proposed Tutorial’s objectives, the targeted audience, and an
overview of what the participants stand to learn
6. Preliminary program:

Please refer to the enclosed list of Session topics to be selected for a Type II
Hematology Tutorial. The list of main topics includes the following subjects: Myeloid
malignancies, Lymphoid malignancies, Anemia and Myelodysplasia

For a two-day Tutorial, you will have to select 6 session topics from the list and
the Faculty will include 6 participants

For a two-and a half day Tutorial, you will have to select 7-8 session topics from
the list and the Faculty will include 8 participants
7. Suggested Faculty

The faculty list should include chairs, co-chairs and local invited speakers who
have tentatively accepted to participate to the Type II Tutorial. At least one speaker
should be a member of EHATol Unit.

Faculty members should be informed that a teaching manual will be distributed
to the participants. Faculty members are expected to contribute a 2-3-page summary of
their lecture accompanied by a list of references to guide further reading.

All faculty members are required to complete an on-line disclosure form at
http://cme.ehaweb.org/ to report any potential conflict of interest.

A fully developed list of potential providers of unrestricted educational grants
who may be interested in funding the tutorial. This list should include the name and
position of the contact person, and complete contact information.
RESPONSIBILITIES OF THE LOCAL ORGANIZERS:

Hematology Tutorials Type II are part of EHA’s Outreach program. This means
that the event is aimed at the participants from your country and the countries nearby.
Please note that it is the responsibility of the local organizers to perform an extensive
local promotion to ensure sufficient participation of local delegates for the tutorial. The
minimum number of attendees is 80 participants. The Sponsorship Policy is outlined in
the Sponsor Prospectus that will be provided to the local organizers, once the
application for the tutorial is accepted. The local organizers will be informed about the
budget of the event including breakdown. The local organizers guarantee a financial
contribution of 50% of the total budget of the event from sponsoring or other funds.

The local organizers are requested to recommend an appropriate venue, which
can accommodate up to 150 people.

The registration fee for the tutorial is 280 Euros. Individual participants (as well
as groups) are requested to register and pay the registration fee online. The
registration link will be available on the EHA website.

EHA-ESH has the right to cancel the event in case of insufficient participation
and/or lack of funding. A decision to cancel the event can be taken 6-4 weeks before
the date of the meeting and depends on the cancellation policy of the booked venue.
RESPONSIBILITIES OF EHA-ESH

EHA will handle all logistical aspects of the tutorial organization, promotion,
official invitations to the speakers, registration of the participants, the educational
materials of the tutorial and the Voting Box System (including all financial aspects of
organization).

EHA will financially contribute to the Tutorial. Based on the budget the EHA
Board will decide on the level of financial support. Pre-condition is that EHA should
have funds available for this.
The tutorial will be considered officially confirmed after an agreement between EHA and
the local organizers, stating the full list of responsibilities, is signed.
CONTACT:
Victoria Chuvakova
European Hematology Association
Koninginnegracht 12b
2514 AA The Hague, The Netherlands
Tel: +31 (0)70 3020 099
Fax: +31 (0)70 3923 663
Email: v.chuvakova@ehaweb.org
Http://www.ehaweb.org
ANNEX: LIST OF SESSION TOPICS FOR HEMATOLOGY TUTORIALS TYPE II
AND III
Before preparing your program, please choose the main topic among Anemia, Myeloid
Malignacies, Lymphoid Malignancies. For the following list of topics, two clinical cases and two
test cases are available.
ANEMIA
1. Normal and reactive bone marrow morphology
2. Normal bone marrow flow- cytometry
3. Red blood cell morphology
4. Genetics and anemia
5. Anemia management
6. Thalassemias: successes and challenges
7. Thalassemia Intermedia
8. Sickle cell disease: current understanding and management
9. Blood transfusions in Sickle cell disease
MYELOID MALIGNANCIES
MYELODYSPLASTIC SYNDROMES
1. Dysplastic blood cell morphology
2. Dysplasia and non clonal diseases
3. Myelodysplastic syndromes
4. Diagnostic criteria in MDS : classification and morphology
5. Differential diagnosis : Hypoplasic MDS/AML, EPN, Marrow aplasia
6. Flow cytometry in MDS
7. Cytogenetics in MDS
8. Prognostic factors in MDS
9. Treatment in MDS
MYELOPROLIPHERATIVE NEOPLASMS
1. WHO classifications of myeloid malignancies
2. Morphology in MPN and in MDS/MPN
3. Flow-cytometry in MPN
4. Genetics and molecular genetics in MPN
5. Chronic Myeloid Leukemia
6. Clinics/therapeutics in CML
7. Clinics/therapeutics in other MPN
ACUTE MYELOID LEUKEMIAS
1. WHO classification and morphology in AML
2. Genetics and molecular genetics in AML
3. Clinics/therapeutics in AML
4. Acute promyelocytic leukemia
5. Leukemias with recurrent cytogenetic translocation
6. AML not otherwise catagorised
7. AML with multilineage dysplasia
8. Eosinophilic leukaemias
9. Systemic mastocytosis
10. Undifferentiated and biphenotypic leukemias
11. Therapy-related leukemias
LYMPHOID MALIGNANCIES
LYMPHOPROLIPHERATIVE DISORDERS
1. WHO classification of lymphoid malignancies
2. Morphology in LPDs
3. Flow-cytometry in LPDs
4. Genetics and molecular genetics in B-LPDs
5. Chronic lymphocytic leukemia
6. Follicular Lymphoma
7. Villous lymphocytes lymphomas
8. Leukemic phase of B-lineage NHL
9. Viruses and lymphoma
10. Gastrointestinal Lymphomas
11. T-cell and natural killer (NK) cell neoplasms
12. Multiple myeloma
13. Hodgkin’s disease
ACUTE LYMPHOID LEUKEMIAS
1. WHO classification and morphology in ALL
2. Genetics and molecular genetics in ALL
3. Flow-cytometry in ALL
4. Clinics/therapeutics in ALL
5. Acute lymphoblastic leukemia
6. Leukemias in children and adolescents